Financials in USD. Standardized financial statements.
A compact view of how ObsEva S.A. turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $19.64M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Revenue Growth? | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit? | $19.64M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Margin? | +100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $35.31M | $54.51M | $79.70M | $107.09M | $77.15M | $67.46M | $30.14M | $19.85M | $12.96M |
| Operating Income? | -$15.68M | -$54.51M | -$79.70M | -$107.09M | -$77.15M | -$67.46M | -$30.14M | -$19.83M | -$12.92M |
| EBITDA? | -$20.07M | -$70.95M | -$78.33M | -$105.50M | -$76.65M | -$66.80M | -$30.06M | -$19.79M | -$12.79M |
| Income Before Tax | -$29.87M | -$58.16M | -$82.93M | -$108.72M | -$76.76M | -$66.88M | -$30.20M | -$19.87M | -$12.81M |
| Income Tax Expense | $11,000 | $212,000 | $34,000 | $67,000 | -$45,000 | $51,000 | $36,000 | $0 | $109,000 |
| Net Income? | -$29.88M | -$58.38M | -$82.97M | -$108.79M | -$76.72M | -$66.93M | -$30.20M | -$19.87M | -$12.81M |
| EPS? | $-0.32 | $-0.78 | $-1.67 | $-2.49 | $-1.91 | $-2.25 | $-1.02 | $-0.67 | $-0.43 |
| Diluted EPS? | $-0.32 | $-0.78 | $-1.67 | $-2.49 | $-1.91 | $-2.25 | $-1.02 | $-0.67 | $-0.43 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality